66.81
price up icon1.20%   0.79
after-market After Hours: 66.81
loading
Edwards Lifesciences Corp stock is traded at $66.81, with a volume of 5.62M. It is up +1.20% in the last 24 hours and up +7.74% over the past month. Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
See More
Previous Close:
$66.02
Open:
$66.23
24h Volume:
5.62M
Relative Volume:
1.09
Market Cap:
$40.25B
Revenue:
$6.00B
Net Income/Loss:
$1.47B
P/E Ratio:
28.55
EPS:
2.34
Net Cash Flow:
$551.80M
1W Performance:
-4.50%
1M Performance:
+7.74%
6M Performance:
-24.36%
1Y Performance:
-13.19%
1-Day Range:
Value
$65.47
$67.04
1-Week Range:
Value
$64.70
$69.96
52-Week Range:
Value
$58.93
$96.12

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
Name
Edwards Lifesciences Corp
Name
Phone
(949) 250-2500
Name
Address
ONE EDWARDS WAY, IRVINE, CA
Name
Employee
19,800
Name
Twitter
@edwardslifesci
Name
Next Earnings Date
2024-07-24
Name
Latest SEC Filings
Name
EW's Discussions on Twitter

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-02-24 Upgrade Wells Fargo Equal Weight → Overweight
Jan-04-24 Downgrade Evercore ISI Outperform → In-line
Dec-11-23 Downgrade Citigroup Buy → Neutral
Nov-28-23 Downgrade Wolfe Research Peer Perform → Underperform
Sep-26-23 Upgrade Oppenheimer Perform → Outperform
Jul-19-23 Initiated Robert W. Baird Outperform
May-30-23 Resumed Morgan Stanley Overweight
Mar-29-23 Initiated UBS Neutral
Mar-08-23 Downgrade Wells Fargo Overweight → Equal Weight
Feb-06-23 Downgrade Raymond James Outperform → Mkt Perform
Jan-31-23 Downgrade Bernstein Outperform → Underperform
Jan-30-23 Downgrade Piper Sandler Overweight → Neutral
Dec-06-22 Downgrade Stifel Buy → Hold
Oct-28-22 Downgrade Oppenheimer Outperform → Perform
Oct-26-22 Initiated Mizuho Buy
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Buy
Jul-29-22 Downgrade Canaccord Genuity Buy → Hold
Apr-13-22 Initiated Truist Buy
Apr-06-22 Initiated Wolfe Research Outperform
Mar-16-22 Upgrade Bernstein Mkt Perform → Outperform
Mar-02-22 Resumed BofA Securities Neutral
Feb-02-22 Upgrade UBS Neutral → Buy
Jan-27-22 Reiterated Citigroup Buy
Jan-27-22 Reiterated Evercore ISI Outperform
Jan-27-22 Reiterated Raymond James Outperform
Jan-27-22 Reiterated Stifel Buy
Jan-27-22 Reiterated UBS Neutral
Dec-17-21 Upgrade JP Morgan Neutral → Overweight
Dec-15-21 Upgrade Citigroup Neutral → Buy
Dec-10-21 Initiated RBC Capital Mkts Outperform
Dec-06-21 Upgrade Wells Fargo Equal Weight → Overweight
Jul-30-21 Reiterated Canaccord Genuity Buy
Jul-30-21 Reiterated Deutsche Bank Hold
Jul-30-21 Reiterated Jefferies Buy
Jul-30-21 Reiterated Morgan Stanley Overweight
Jul-30-21 Reiterated Oppenheimer Outperform
Jul-30-21 Reiterated Stifel Buy
Jul-30-21 Reiterated UBS Neutral
Jul-30-21 Reiterated Wells Fargo Equal Weight
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Neutral
Apr-05-21 Upgrade Evercore ISI In-line → Outperform
Dec-16-20 Downgrade Citigroup Buy → Neutral
Dec-11-20 Reiterated Canaccord Genuity Buy
Sep-11-20 Initiated Wolfe Research Underperform
Apr-28-20 Downgrade Wells Fargo Overweight → Equal Weight
Apr-17-20 Upgrade SVB Leerink Mkt Perform → Outperform
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Neutral
Feb-06-20 Resumed BTIG Research Neutral
Jan-10-20 Initiated Oppenheimer Outperform
Jan-02-20 Downgrade Evercore ISI Outperform → In-line
Oct-24-19 Reiterated Canaccord Genuity Buy
Sep-23-19 Initiated Piper Jaffray Overweight
Jul-24-19 Reiterated BofA/Merrill Buy
Mar-18-19 Reiterated Canaccord Genuity Buy
Jan-18-19 Upgrade BofA/Merrill Neutral → Buy
Jan-03-19 Initiated Deutsche Bank Hold
Nov-28-18 Initiated UBS Neutral
Oct-16-18 Initiated Barclays Underweight
Oct-02-18 Downgrade BofA/Merrill Buy → Neutral
Oct-02-18 Downgrade Guggenheim Buy → Neutral
View All

Edwards Lifesciences Corp Stock (EW) Latest News

pulisher
Sep 08, 2024

We Think Edwards Lifesciences (NYSE:EW) Can Manage Its Debt With Ease - Yahoo Finance

Sep 08, 2024
pulisher
Sep 08, 2024

Candriam S.C.A. Buys 150,662 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Sep 08, 2024
pulisher
Sep 07, 2024

National Bank of Canada FI Purchases 34,635 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Sep 07, 2024
pulisher
Sep 06, 2024

TD Asset Management Inc Sells 48,443 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Sep 06, 2024
pulisher
Sep 06, 2024

Edwards’ Sapien TAVR devices superior to SAVR in women - BioWorld Online

Sep 06, 2024
pulisher
Sep 06, 2024

Does Edwards Lifesciences (NYQ:EW) have an economic moat? - Yahoo Finance UK

Sep 06, 2024
pulisher
Sep 06, 2024

Edwards Lifesciences Co. (NYSE:EW) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Sep 06, 2024
pulisher
Sep 05, 2024

Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors - MarketWatch

Sep 05, 2024
pulisher
Sep 05, 2024

Edwards cuts more than 500 employees after critical care sale - Yahoo Finance

Sep 05, 2024
pulisher
Sep 04, 2024

Edwards Lifesciences starts global layoffs - Mass Device

Sep 04, 2024
pulisher
Sep 04, 2024

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Sep 04, 2024
pulisher
Sep 04, 2024

Edwards Lifesciences Completes $4.2B Sale of Critical Care to BD - Yahoo Finance

Sep 04, 2024
pulisher
Sep 04, 2024

BD completes acquisition of Edwards Lifesciences’ Critical Care product group - Medical Device Network

Sep 04, 2024
pulisher
Sep 03, 2024

Edwards Lifesciences Completes Sale of Critical Care - Quantisnow

Sep 03, 2024
pulisher
Sep 03, 2024

BD acquires Edwards Lifesciences unit for smart care - Investing.com

Sep 03, 2024
pulisher
Sep 03, 2024

Edwards Lifesciences Completes Sale of Critical Care - Yahoo Finance UK

Sep 03, 2024
pulisher
Sep 03, 2024

BD Completes Acquisition of Critical Care from Edwards Lifesciences – Company Announcement - Financial Times

Sep 03, 2024
pulisher
Sep 03, 2024

Spire Wealth Management Has $359,000 Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Sep 03, 2024
pulisher
Sep 02, 2024

Edwards Lifesciences Co. (NYSE:EW) Shares Sold by Van ECK Associates Corp - MarketBeat

Sep 02, 2024
pulisher
Sep 02, 2024

Edwards Lifesciences reports positive TAVI trial results - Medical Device Network

Sep 02, 2024
pulisher
Sep 01, 2024

Mirova US LLC Acquires 17,365 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Sep 01, 2024
pulisher
Aug 30, 2024

Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future - Simply Wall St

Aug 30, 2024
pulisher
Aug 29, 2024

5 of the Best Stocks to Buy Now | Investing - U.S News & World Report Money

Aug 29, 2024
pulisher
Aug 29, 2024

Traders Buy High Volume of Put Options on Edwards Lifesciences (NYSE:EW) - MarketBeat

Aug 29, 2024
pulisher
Aug 29, 2024

Investors in Edwards Lifesciences (NYSE:EW) have unfortunately lost 43% over the last three years - Yahoo Finance

Aug 29, 2024
pulisher
Aug 28, 2024

Kintegral Advisory LLC Has $6.74 Million Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Aug 28, 2024
pulisher
Aug 27, 2024

The Broad Impact of Edwards v. Meril on the Safe Harbor Provision - The National Law Review

Aug 27, 2024
pulisher
Aug 26, 2024

Calamos Advisors LLC Decreases Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Aug 26, 2024
pulisher
Aug 26, 2024

Intracardiac Oximeter Market Growing Rapidly by 2031- Edwards Lifesciences Corporation, Medtronic - openPR

Aug 26, 2024
pulisher
Aug 25, 2024

Edwards Lifesciences Co. (NYSE:EW) Shares Sold by Baillie Gifford & Co. - MarketBeat

Aug 25, 2024
pulisher
Aug 25, 2024

Could The Market Be Wrong About Edwards Lifesciences Corporation (NYSE:EW) Given Its Attractive Financial Prospects? - Yahoo Finance

Aug 25, 2024
pulisher
Aug 23, 2024

Edwards Lifesciences (EW) Up 19.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Aug 23, 2024
pulisher
Aug 22, 2024

Edwards Lifesciences Co. (NYSE:EW) Shares Sold by Fifth Third Bancorp - Defense World

Aug 22, 2024
pulisher
Aug 22, 2024

Catheters Market Set to Reach USD 99.30 Billion by 2032, Growing at a CAGR of 7.2% | Polaris Market Research - GlobeNewswire Inc.

Aug 22, 2024
pulisher
Aug 22, 2024

Edwards Lifesciences stock set for rebound amid TMTT optimismCiti - Investing.com

Aug 22, 2024
pulisher
Aug 21, 2024

Chevy Chase Trust Holdings LLC Cuts Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Aug 21, 2024
pulisher
Aug 21, 2024

Edwards Lifesciences executive sells over $87k in company stock By Investing.com - Investing.com Australia

Aug 21, 2024
pulisher
Aug 21, 2024

Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference - sharewise

Aug 21, 2024
pulisher
Aug 21, 2024

Edwards Lifesciences Co. (NYSE:EW) VP Daveen Chopra Sells 1,250 Shares - Defense World

Aug 21, 2024
pulisher
Aug 21, 2024

Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference - Yahoo Finance

Aug 21, 2024
pulisher
Aug 21, 2024

Edwards Lifesciences executive sells over $87k in company stock By Investing.com - Investing.com Canada

Aug 21, 2024
pulisher
Aug 21, 2024

Edwards Lifesciences executive sells over $87k in company stock - Investing.com India

Aug 21, 2024
pulisher
Aug 20, 2024

Insider Selling: Edwards Lifesciences Co. (NYSE:EW) VP Sells 1,250 Shares of Stock - MarketBeat

Aug 20, 2024
pulisher
Aug 20, 2024

Edwards Lifesciences executive sells over $87k in company stock - Investing.com

Aug 20, 2024
pulisher
Aug 20, 2024

Edwards Lifesciences executive sells over $87k in company stock By Investing.com - Investing.com UK

Aug 20, 2024
pulisher
Aug 20, 2024

Edwards Lifesciences (NYSE:EW) Trading Up 2.3% - MarketBeat

Aug 20, 2024
pulisher
Aug 20, 2024

Edwards Buys JC Medical from Genesis MedTech - Orange County Business Journal

Aug 20, 2024
pulisher
Aug 20, 2024

Edwards Lifesciences acquires JC Medical from Genesis Medtech - Medical Device Network

Aug 20, 2024
pulisher
Aug 20, 2024

Edwards Lifesciences acquires JC Medical from Genesis Medtech - Yahoo Finance

Aug 20, 2024
pulisher
Aug 19, 2024

Edwards Lifesciences (BSP:E1WL34) PB Ratio : 1.42 (As of Aug. 19, 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

Edwards Lifesciences maintains neutral rating with $73 target - Investing.com

Aug 19, 2024

Edwards Lifesciences Corp Stock (EW) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$85.09
price down icon 2.52%
medical_devices PHG
$30.22
price up icon 1.31%
$68.61
price down icon 0.64%
medical_devices STE
$239.82
price up icon 0.32%
medical_devices ZBH
$104.81
price up icon 0.33%
Cap:     |  Volume (24h):